|
SMi is proud to announce its 7th Annual Conference on the Advances and Progress of Drug Design. Drug design is the fundamental step to ensuring that only the safest and most efficacious drugs are brought to the public. This conference will gather the top industry experts to discuss, debate and learn about the newest developments of the drug design industry, to guarantee a better future for individual and national health. - Discover the future drug design by hearing about new breakthrough technology and their impact on the pharmaceuticals market.
- Obtain comprehensive insight into the world of drug design from all stages of research and development.
- Receive accounts of case studies and examples of successful drug design campaigns.
- Learn about the newest developments and how this knowledge can impact current research.
- Examine previous drug design campaigns and where they can be improved to ensure success in the future.
Confirmed speakers include: - Dr Jonathan S Mason, Divisional Director, Lundbeck Research DK
- Dr Han van de Waterbeemd, Global Project Leader, AstraZeneca
- Dr Michael Arlt, Department Manager, Global Medicinal Chemistry Lead Finding, Merck KGaA
- Dr Anny-Odile Colson, Research Investigator, Novartis
- Zhengming Chen, Senior Director, Chemistry and CMC, DOV Pharmaceutical
- Richard Friesner, Professor of Chemistry, Schroedinger Chairman and Founder, Columbia University
Who should attend: Scientific Research Managers Principal Scientists Medicinal Chemists Director, Computational Chemistry Director, Molecular Modelling Director, Pharmaceutical Research Director, Drug Discovery
|
Events Home Page
